37
MPM BioImpact Innovations Equities Master, LP updates its Form D — $105.2M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $105.2M · BOSTON, MA · filed 2026-06-26
3(c)(7) — qualified purchasers
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
| Christopher Goh Wolf | Mr. Wolf is the Chief Financial Officer and Authorized Signatory of the General Partner of the Issuer |
| n/a MPM BioImpact Innovations Equities GP, LLC | The General Partner of the Issuer. |
| Christiana Goh Bardon | Dr. Bardon is the Managing Member of the General Partner of the Issuer and the Co-Managing Partner of MPM BioImpact LLC, the Investment Manager of the Issuer. |
| Kristen Goh Laguerre | Ms. Laguerre is the Partner, Finance and Operations and Authorized Signatory of the General Partner of the Issuer |
Signed by Christopher Wolf, Authorized Signatory of the General Partner of the Issuer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.